Fulgent Genetics (FLGT)
(Delayed Data from NSDQ)
$20.78 USD
+2.42 (13.18%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $20.77 -0.01 (-0.05%) 5:40 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
FLGT 20.78 +2.42(13.18%)
Will FLGT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for FLGT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FLGT
Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates
Fulgent Genetics, Inc. (FLGT) Q1 Earnings and Revenues Beat Estimates
FLGT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last?
Fulgent Genetics, Inc. (FLGT) Q4 Earnings and Revenues Beat Estimates
TruBridge (TBRG) Soars 6.4%: Is Further Upside Left in the Stock?
Other News for FLGT
UBS Upgrades Fulgent Genetics (FLGT) to 'Buy', Increases Price Target to $30 | FLGT Stock News
UBS Upgrades Fulgent Genetics (FLGT) With Increased Price Target
Fulgent Genetics just upgraded at UBS, here's why
Bullish Two Hundred Day Moving Average Cross - FLGT
Notable Tuesday Option Activity: FLGT, CODI, TDG